世界の内分泌ペプチド検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Endocrine Peptides Test Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2148
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、内分泌ペプチド検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エストラジオール（E2）、デヒドロエピアンドロステロン硫酸塩（DHEAS）、ヒト絨毛性ゴナドトロピン（hCG）、プロゲステロン、黄体形成ホルモン（LH）、甲状腺刺激ホルモン（TSH）、甲状腺プロラクチン、その他）、用途別市場規模（病院、医師オフィス、商業研究所、医療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・内分泌ペプチド検査の市場動向
・企業の競争状況、市場シェア
・内分泌ペプチド検査の種類別市場規模（エストラジオール（E2）、デヒドロエピアンドロステロン硫酸塩（DHEAS）、ヒト絨毛性ゴナドトロピン（hCG）、プロゲステロン、黄体形成ホルモン（LH）、甲状腺刺激ホルモン（TSH）、甲状腺プロラクチン、その他）
・内分泌ペプチド検査の用途別市場規模（病院、医師オフィス、商業研究所、医療センター）
・内分泌ペプチド検査の北米市場規模2016-2027（アメリカ、カナダ）
・内分泌ペプチド検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・内分泌ペプチド検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・内分泌ペプチド検査の中南米市場規模2016-2027（メキシコ、ブラジル）
・内分泌ペプチド検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Quest Diagnostics、Siemens Healthcare、Abbott Laboratories、bioMerieux）
・結論

Endocrine peptide test is used for the measurement of the level of c-peptide present in the blood. C-peptide and insulin are usually found in equivalent amounts.

Market Analysis and Insights: Global Endocrine Peptides Test Market
The global Endocrine Peptides Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endocrine Peptides Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endocrine Peptides Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endocrine Peptides Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endocrine Peptides Test market.

Global Endocrine Peptides Test Scope and Market Size
Endocrine Peptides Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endocrine Peptides Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Estradiol (E2)
Dehydroepiandrosterone Sulfate (DHEAS)
Human Chorionic Gonadotropin (hCG)
Progesterone, Luteinizing Hormone (LH)
Thyroid Stimulating Hormone (TSH)
Thyroid Prolactin
Others

Segment by Application
Hospitals
Physicians’ offices
Commercial Laboratories
Health Care Centers

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Quest Diagnostics
Siemens Healthcare
Abbott Laboratories

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Peptides Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Estradiol (E2)
1.2.3 Dehydroepiandrosterone Sulfate (DHEAS)
1.2.4 Human Chorionic Gonadotropin (hCG)
1.2.5 Progesterone, Luteinizing Hormone (LH)
1.2.6 Thyroid Stimulating Hormone (TSH)
1.2.7 Thyroid Prolactin
1.2.8 Others
1.3 Market by Application
1.3.1 Global Endocrine Peptides Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Physicians’ offices
1.3.4 Commercial Laboratories
1.3.5 Health Care Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Endocrine Peptides Test Market Perspective (2016-2027)
2.2 Endocrine Peptides Test Growth Trends by Regions
2.2.1 Endocrine Peptides Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endocrine Peptides Test Historic Market Share by Regions (2016-2021)
2.2.3 Endocrine Peptides Test Forecasted Market Size by Regions (2022-2027)
2.3 Endocrine Peptides Test Industry Dynamic
2.3.1 Endocrine Peptides Test Market Trends
2.3.2 Endocrine Peptides Test Market Drivers
2.3.3 Endocrine Peptides Test Market Challenges
2.3.4 Endocrine Peptides Test Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Endocrine Peptides Test Players by Revenue
3.1.1 Global Top Endocrine Peptides Test Players by Revenue (2016-2021)
3.1.2 Global Endocrine Peptides Test Revenue Market Share by Players (2016-2021)
3.2 Global Endocrine Peptides Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endocrine Peptides Test Revenue
3.4 Global Endocrine Peptides Test Market Concentration Ratio
3.4.1 Global Endocrine Peptides Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Peptides Test Revenue in 2020
3.5 Endocrine Peptides Test Key Players Head office and Area Served
3.6 Key Players Endocrine Peptides Test Product Solution and Service
3.7 Date of Enter into Endocrine Peptides Test Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Endocrine Peptides Test Breakdown Data by Type
4.1 Global Endocrine Peptides Test Historic Market Size by Type (2016-2021)
4.2 Global Endocrine Peptides Test Forecasted Market Size by Type (2022-2027)

5 Endocrine Peptides Test Breakdown Data by Application
5.1 Global Endocrine Peptides Test Historic Market Size by Application (2016-2021)
5.2 Global Endocrine Peptides Test Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Endocrine Peptides Test Market Size (2016-2027)
6.2 North America Endocrine Peptides Test Market Size by Type
6.2.1 North America Endocrine Peptides Test Market Size by Type (2016-2021)
6.2.2 North America Endocrine Peptides Test Market Size by Type (2022-2027)
6.2.3 North America Endocrine Peptides Test Market Size by Type (2016-2027)
6.3 North America Endocrine Peptides Test Market Size by Application
6.3.1 North America Endocrine Peptides Test Market Size by Application (2016-2021)
6.3.2 North America Endocrine Peptides Test Market Size by Application (2022-2027)
6.3.3 North America Endocrine Peptides Test Market Size by Application (2016-2027)
6.4 North America Endocrine Peptides Test Market Size by Country
6.4.1 North America Endocrine Peptides Test Market Size by Country (2016-2021)
6.4.2 North America Endocrine Peptides Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Endocrine Peptides Test Market Size (2016-2027)
7.2 Europe Endocrine Peptides Test Market Size by Type
7.2.1 Europe Endocrine Peptides Test Market Size by Type (2016-2021)
7.2.2 Europe Endocrine Peptides Test Market Size by Type (2022-2027)
7.2.3 Europe Endocrine Peptides Test Market Size by Type (2016-2027)
7.3 Europe Endocrine Peptides Test Market Size by Application
7.3.1 Europe Endocrine Peptides Test Market Size by Application (2016-2021)
7.3.2 Europe Endocrine Peptides Test Market Size by Application (2022-2027)
7.3.3 Europe Endocrine Peptides Test Market Size by Application (2016-2027)
7.4 Europe Endocrine Peptides Test Market Size by Country
7.4.1 Europe Endocrine Peptides Test Market Size by Country (2016-2021)
7.4.2 Europe Endocrine Peptides Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Endocrine Peptides Test Market Size (2016-2027)
8.2 Asia-Pacific Endocrine Peptides Test Market Size by Type
8.2.1 Asia-Pacific Endocrine Peptides Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endocrine Peptides Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endocrine Peptides Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Endocrine Peptides Test Market Size by Application
8.3.1 Asia-Pacific Endocrine Peptides Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endocrine Peptides Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endocrine Peptides Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Endocrine Peptides Test Market Size by Region
8.4.1 Asia-Pacific Endocrine Peptides Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endocrine Peptides Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Endocrine Peptides Test Market Size (2016-2027)
9.2 Latin America Endocrine Peptides Test Market Size by Type
9.2.1 Latin America Endocrine Peptides Test Market Size by Type (2016-2021)
9.2.2 Latin America Endocrine Peptides Test Market Size by Type (2022-2027)
9.2.3 Latin America Endocrine Peptides Test Market Size by Type (2016-2027)
9.3 Latin America Endocrine Peptides Test Market Size by Application
9.3.1 Latin America Endocrine Peptides Test Market Size by Application (2016-2021)
9.3.2 Latin America Endocrine Peptides Test Market Size by Application (2022-2027)
9.3.3 Latin America Endocrine Peptides Test Market Size by Application (2016-2027)
9.4 Latin America Endocrine Peptides Test Market Size by Country
9.4.1 Latin America Endocrine Peptides Test Market Size by Country (2016-2021)
9.4.2 Latin America Endocrine Peptides Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Endocrine Peptides Test Market Size (2016-2027)
10.2 Middle East & Africa Endocrine Peptides Test Market Size by Type
10.2.1 Middle East & Africa Endocrine Peptides Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endocrine Peptides Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endocrine Peptides Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Endocrine Peptides Test Market Size by Application
10.3.1 Middle East & Africa Endocrine Peptides Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endocrine Peptides Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endocrine Peptides Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Endocrine Peptides Test Market Size by Country
10.4.1 Middle East & Africa Endocrine Peptides Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endocrine Peptides Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Endocrine Peptides Test Introduction
11.1.4 Quest Diagnostics Revenue in Endocrine Peptides Test Business (2016-2021)
11.1.5 Quest Diagnostics Recent Development
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Details
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Endocrine Peptides Test Introduction
11.2.4 Siemens Healthcare Revenue in Endocrine Peptides Test Business (2016-2021)
11.2.5 Siemens Healthcare Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Endocrine Peptides Test Introduction
11.3.4 Abbott Laboratories Revenue in Endocrine Peptides Test Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 bioMerieux
11.4.1 bioMerieux Company Details
11.4.2 bioMerieux Business Overview
11.4.3 bioMerieux Endocrine Peptides Test Introduction
11.4.4 bioMerieux Revenue in Endocrine Peptides Test Business (2016-2021)
11.4.5 bioMerieux Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Endocrine Peptides Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Estradiol (E2)
Table 3. Key Players of Dehydroepiandrosterone Sulfate (DHEAS)
Table 4. Key Players of Human Chorionic Gonadotropin (hCG)
Table 5. Key Players of Progesterone, Luteinizing Hormone (LH)
Table 6. Key Players of Thyroid Stimulating Hormone (TSH)
Table 7. Key Players of Thyroid Prolactin
Table 8. Key Players of Others
Table 9. Global Endocrine Peptides Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Endocrine Peptides Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Endocrine Peptides Test Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Endocrine Peptides Test Market Share by Regions (2016-2021)
Table 13. Global Endocrine Peptides Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Endocrine Peptides Test Market Share by Regions (2022-2027)
Table 15. Endocrine Peptides Test Market Trends
Table 16. Endocrine Peptides Test Market Drivers
Table 17. Endocrine Peptides Test Market Challenges
Table 18. Endocrine Peptides Test Market Restraints
Table 19. Global Endocrine Peptides Test Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Endocrine Peptides Test Market Share by Players (2016-2021)
Table 21. Global Top Endocrine Peptides Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine Peptides Test as of 2020)
Table 22. Ranking of Global Top Endocrine Peptides Test Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Endocrine Peptides Test Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Endocrine Peptides Test Product Solution and Service
Table 26. Date of Enter into Endocrine Peptides Test Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Endocrine Peptides Test Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Endocrine Peptides Test Revenue Market Share by Type (2016-2021)
Table 30. Global Endocrine Peptides Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Endocrine Peptides Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Endocrine Peptides Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Endocrine Peptides Test Revenue Market Share by Application (2016-2021)
Table 34. Global Endocrine Peptides Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Endocrine Peptides Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Endocrine Peptides Test Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Endocrine Peptides Test Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Endocrine Peptides Test Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Endocrine Peptides Test Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Endocrine Peptides Test Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Endocrine Peptides Test Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Endocrine Peptides Test Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Endocrine Peptides Test Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Endocrine Peptides Test Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Endocrine Peptides Test Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Endocrine Peptides Test Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Endocrine Peptides Test Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Endocrine Peptides Test Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Endocrine Peptides Test Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Endocrine Peptides Test Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Endocrine Peptides Test Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Endocrine Peptides Test Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Endocrine Peptides Test Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Endocrine Peptides Test Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Endocrine Peptides Test Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Endocrine Peptides Test Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Endocrine Peptides Test Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Endocrine Peptides Test Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Endocrine Peptides Test Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Endocrine Peptides Test Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Endocrine Peptides Test Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Endocrine Peptides Test Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Endocrine Peptides Test Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Endocrine Peptides Test Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Endocrine Peptides Test Market Size by Country (2022-2027) & (US$ Million)
Table 66. Quest Diagnostics Company Details
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Endocrine Peptides Test Product
Table 69. Quest Diagnostics Revenue in Endocrine Peptides Test Business (2016-2021) & (US$ Million)
Table 70. Quest Diagnostics Recent Development
Table 71. Siemens Healthcare Company Details
Table 72. Siemens Healthcare Business Overview
Table 73. Siemens Healthcare Endocrine Peptides Test Product
Table 74. Siemens Healthcare Revenue in Endocrine Peptides Test Business (2016-2021) & (US$ Million)
Table 75. Siemens Healthcare Recent Development
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Endocrine Peptides Test Product
Table 79. Abbott Laboratories Revenue in Endocrine Peptides Test Business (2016-2021) & (US$ Million)
Table 80. Abbott Laboratories Recent Development
Table 81. bioMerieux Company Details
Table 82. bioMerieux Business Overview
Table 83. bioMerieux Endocrine Peptides Test Product
Table 84. bioMerieux Revenue in Endocrine Peptides Test Business (2016-2021) & (US$ Million)
Table 85. bioMerieux Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocrine Peptides Test Market Share by Type: 2020 VS 2027
Figure 2. Estradiol (E2) Features
Figure 3. Dehydroepiandrosterone Sulfate (DHEAS) Features
Figure 4. Human Chorionic Gonadotropin (hCG) Features
Figure 5. Progesterone, Luteinizing Hormone (LH) Features
Figure 6. Thyroid Stimulating Hormone (TSH) Features
Figure 7. Thyroid Prolactin Features
Figure 8. Others Features
Figure 9. Global Endocrine Peptides Test Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Physicians’ offices Case Studies
Figure 12. Commercial Laboratories Case Studies
Figure 13. Health Care Centers Case Studies
Figure 14. Endocrine Peptides Test Report Years Considered
Figure 15. Global Endocrine Peptides Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Endocrine Peptides Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Endocrine Peptides Test Market Share by Regions: 2020 VS 2027
Figure 18. Global Endocrine Peptides Test Market Share by Regions (2022-2027)
Figure 19. Global Endocrine Peptides Test Market Share by Players in 2020
Figure 20. Global Top Endocrine Peptides Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine Peptides Test as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Endocrine Peptides Test Revenue in 2020
Figure 22. Global Endocrine Peptides Test Revenue Market Share by Type (2016-2021)
Figure 23. Global Endocrine Peptides Test Revenue Market Share by Type (2022-2027)
Figure 24. North America Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Endocrine Peptides Test Market Share by Type (2016-2027)
Figure 26. North America Endocrine Peptides Test Market Share by Application (2016-2027)
Figure 27. North America Endocrine Peptides Test Market Share by Country (2016-2027)
Figure 28. United States Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Endocrine Peptides Test Market Share by Type (2016-2027)
Figure 32. Europe Endocrine Peptides Test Market Share by Application (2016-2027)
Figure 33. Europe Endocrine Peptides Test Market Share by Country (2016-2027)
Figure 34. Germany Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Endocrine Peptides Test Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Endocrine Peptides Test Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Endocrine Peptides Test Market Share by Region (2016-2027)
Figure 44. China Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Endocrine Peptides Test Market Share by Type (2016-2027)
Figure 52. Latin America Endocrine Peptides Test Market Share by Application (2016-2027)
Figure 53. Latin America Endocrine Peptides Test Market Share by Country (2016-2027)
Figure 54. Mexico Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Endocrine Peptides Test Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Endocrine Peptides Test Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Endocrine Peptides Test Market Share by Country (2016-2027)
Figure 60. Turkey Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Endocrine Peptides Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Quest Diagnostics Revenue Growth Rate in Endocrine Peptides Test Business (2016-2021)
Figure 64. Siemens Healthcare Revenue Growth Rate in Endocrine Peptides Test Business (2016-2021)
Figure 65. Abbott Laboratories Revenue Growth Rate in Endocrine Peptides Test Business (2016-2021)
Figure 66. bioMerieux Revenue Growth Rate in Endocrine Peptides Test Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の内分泌ペプチド検査市場規模・現状・予測（2021年-2027年）

Global Endocrine Peptides Test Market Size, Status and Forecast 2021-2027
QYR2104Z2148 2021年4月 96Pages
QYResearch社発行の本調査資料では、内分泌ペプチド検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エストラジオール（E2）、デヒドロエピアンドロステロン硫酸塩（DHEAS）、ヒト絨毛性ゴナドトロピン（hCG）、プロゲステロン、黄体形...

世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Endocrine Neoplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3952 2021年4月 97Pages
QYResearch社発行の本調査資料では、多発性内分泌腺腫症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界のペプチドバイオシミラー市場規模・現状・予測（2021年-2027年）

Global Peptides Biosimilars Market Size, Status and Forecast 2021-2027
QYR2104Z4503 2021年4月 99Pages
QYResearch社発行の本調査資料では、ペプチドバイオシミラーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グルカゴン、カルシトニン）、用途別市場規模（腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他）、主要地域...

世界の希少内分泌疾患治療市場規模・現状・予測（2021年-2027年）

Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4938 2021年4月 97Pages
QYResearch社発行の本調査資料では、希少内分泌疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、有機化合物）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の内分泌検査市場規模・現状・予測（2021年-2027年）

Global Endocrine Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2149 2021年4月 129Pages
QYResearch社発行の本調査資料では、内分泌検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タンデム質量分析、イムノアッセイ）、用途別市場規模（病院、商業研究所、外来診療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の内分泌検査システム市場規模・現状・予測（2021年-2027年）

Global Endocrine Testing System Market Size, Status and Forecast 2021-2027
QYR2104Z2150 2021年4月 133Pages
QYResearch社発行の本調査資料では、内分泌検査システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タンデム質量分析、LC-MS/MS、イムノアッセイ、モノクローナル・ポリクローナル抗体技術、センサー技術、臨床化学、その他）、用途別市...

世界のマスク＆人工呼吸器品質適合試験市場規模・現状・予測（2021年-2027年）

Global Quality Mask and Respirator Fit Test Market Size, Status and Forecast 2021-2027
QYR2104Z4882 2021年4月 94Pages
QYResearch社発行の本調査資料では、マスク＆人工呼吸器品質適合試験のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（良い、悪い）、用途別市場規模（医療、製造、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界の抗原皮膚検査市場規模・現状・予測（2021年-2027年）

Global Antigen Skin Test Market Size, Status and Forecast 2021-2027
QYR2104Z0390 2021年4月 92Pages
QYResearch社発行の本調査資料では、抗原皮膚検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（真菌感染症、細菌感染症、寄生虫感染症）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の神経内分泌機能検査市場規模・現状・予測（2021年-2027年）

Global Neuroendocrine Function Test Market Size, Status and Forecast 2021-2027
QYR2104Z4090 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経内分泌機能検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、薬物治療）、用途別市場規模（病院、診療所、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のM2M通信検査・監視市場規模・現状・予測（2021年-2027年）

Global M2M Communications Test & Monitoring Market Size, Status and Forecast 2021-2027
QYR2104Z3512 2021年4月 93Pages
QYResearch社発行の本調査資料では、M2M通信検査・監視のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（監視、I＆M、製造、R＆D）、用途別市場規模（セルラーM2M試験装置、衛星M2M試験装置、ワイヤレスM2M試験装置）、主要地域別市場...

世界の内分泌ペプチド検査市場規模・現状・予測（2021年-2027年） Endocrine peptide test is used for the measurement of the level of c-peptide present in the blood. C-peptide and insulin are usually found in equivalent amounts. Market Analysis and Insights: Global Endocrine Peptides Test Market The global Endocrine Peptides Test market size is projected to reach …
世界の甲状腺ホーム検査キット市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thyroid Home Test Kits Market The global Thyroid Home Test Kits market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
世界の甲状腺ホーム検査キット市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thyroid Home Test Kits Market The global Thyroid Home Test Kits market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年） Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men.…
世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年） Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men.…